Paradigm Biopharmaceuticals Limited (PBIGF) - Latest Market Data

Price & Market Data

Price: $0.14

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $73,563,936

Daily Volume: 0

Performance Metrics

1 Week: 3.70%

1 Month: -30.00%

3 Months: -39.13%

6 Months: -49.73%

1 Year: -34.88%

YTD: -39.94%

About Paradigm Biopharmaceuticals Limited (PBIGF)

Essential market overview for Paradigm Biopharmaceuticals Limited (PBIGF). Current price: 0.14, daily change: $0.00 / 0.00%. Market cap: 73,563,936. All key performance metrics for a full analysis.

Details

Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.

Selected stocks

High Country Bancorp, Inc. (HCBC)

Waitr Holdings Inc. (ASAPQ)

PS Business Parks, Inc. (PSBXP)

Alba Minerals Resources PLC. (ALBAF)

Victory Marine Holdings Corp. (VMHG)